Nodosis

Quick links to important sections

Nodosis

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nodosis

Quick Facts: Nodosis

Property Description
Active Ingredient Sodium Bicarbonate (NaHCO3)
Form Oral Tablet
Pharmacological Class Systemic Alkalinizer and Antacid
General Purpose Correcting acid-base imbalance (e.g., metabolic acidosis)
Origin/Type Synthetic, single-ingredient product

What Type of Medicine is Nodosis?

Nodosis is a brand-specific pharmaceutical preparation classified primarily as a Systemic Alkalinizer and secondarily as an Antacid. Its active component is Sodium Bicarbonate, an inorganic chemical compound that serves as a source of alkali. Sodium Bicarbonate is a medication used to treat acid-base disorders, reflecting the compound's role in managing systemic acidity. This application highlights the compound's role in stabilizing body chemistry, an effect clinically recognized for decades of pharmacological use. Nodosis is delivered as an Oral Tablet and is designed as a synthetic, single-ingredient product, which simplifies its action to the delivery of the bicarbonate ion.


What is the General Therapeutic Purpose of a Systemic Alkalinizer?

The general therapeutic purpose of a Systemic Alkalinizer like Nodosis is to correct or stabilize the body's pH level when it becomes overly acidic, a condition known as metabolic acidosis. This is achieved through the chemical action of acid neutralization and systemic buffering, where the delivered bicarbonate reacts with excess hydrogen ions. The compound assists in maintaining the body's balance of electrolytes and pH to support vital organ functions. By supporting the body's natural buffering systems, the drug provides relief from symptoms associated with localized hyperacidity, such as heartburn and indigestion, and is used in a therapeutic setting to manage systemic acid burdens.

Regulatory References

  1. National Library of Medicine

What side effects are possible with Nodosis?

Possible Side Effects and Safety Information

The most commonly documented adverse effects of oral Sodium Bicarbonate (Nodosis) are primarily related to its action in the gastrointestinal system. These reactions are generally classified as common in regulatory sources and result from the release of carbon dioxide gas in the stomach.

Adverse Reactions and System-Organ Classifications

System-Organ Class (SOC) Listed Adverse Reactions (Regulatory Terminology) Frequency Classification
Gastrointestinal Disorders Belching, Flatulence, Abdominal distention, Stomach cramps, Nausea, Vomiting Common (for gas-related effects)
Metabolism and Nutrition Metabolic alkalosis, Hypernatremia (high blood sodium), Fluid retention, Hypokalemia Frequency Varies (Associated with use)

Serious adverse reactions documented in official labeling primarily involve systemic electrolyte and fluid balance. The most significant is Metabolic Alkalosis, an overly alkaline state in the body, which is a known risk associated with prolonged use or high doses. Another serious safety concern is Milk-Alkali Syndrome, reported with chronic administration alongside high calcium intake.

Population-Specific Safety Considerations

Official documents advise specific caution for several patient groups due to the drug's high sodium content and the potential for fluid overload. Safety warnings are explicitly noted for individuals with existing congestive heart failure, hypertension, and kidney impairment (renal disease). Furthermore, the regulatory labeling emphasizes that prolonged use of the medicine should be avoided to prevent the development of systemic alkalosis.

Overdose and Emergency Response

The regulatory profile for a Nodosis (Sodium Bicarbonate) overdose emphasizes the immediate risk of Metabolic Alkalosis and severe Electrolyte Imbalance, primarily Hypernatremia and Hypokalemia. Officially documented clinical manifestations of overdose include hyperirritability, tetany (muscle spasms), muscle twitching, and persistent headache. Gastrointestinal symptoms like nausea and vomiting are also listed.

Severe or life-threatening manifestations documented in official labeling include seizures and coma resulting from profound alkalemia. A unique, acute risk associated with oral overdose is spontaneous gastric rupture due to rapid carbon dioxide gas production. Individuals with impaired renal function or congestive heart failure face an increased risk of complications like fluid overload and pulmonary edema from the excess sodium.

Emergency Medical Action: Regulators mandate that immediate medical help must be sought for any suspected overdose. Emergency services must be contacted immediately if the affected person has collapsed, experiences trouble breathing, or has had a seizure. There is no specific antidote documented; treatment focuses on supportive care, continuous monitoring of serum electrolytes and acid-base status, and correctional management of the metabolic alkalosis, potentially including the use of IV fluids and electrolyte replacement.

Therapeutic Uses of Nodosis

What Nodosis Treats: Main Uses and Benefits

Nodosis is considered relevant in therapeutic contexts where short-term symptomatic management is appropriate for patients experiencing certain distressing symptoms. Such supportive relief is commonly used to help with symptom clusters that may suddenly appear or fluctuate. It is used for managing symptoms related to episodic discomfort, heightened tension, or manifestations that may interfere with daily comfort.


Managing Symptom Clusters and Functional Strain

Nodosis is commonly used across domains where additional symptomatic support is needed in situations involving symptoms that appear suddenly or in fluctuating patterns, creating noticeable physiological strain. It is often used when symptoms intensify and supportive relief is needed in settings that involve acute or disruptive symptom patterns and contexts marked by increased discomfort or tension. It supports general well-being during symptomatic phases and contributes to easing the overall symptom load during periods of heightened symptoms.

“Nodosis assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations.”


Quick Facts

  • Quick Fact: Relief for Episodic Symptoms Nodosis is relevant for managing symptom clusters that may become intense or disruptive in situations where symptoms lead to temporary functional strain or discomfort.

Eligibility and Restrictions for Use

Nodosis eligibility is strictly defined by official regulatory documentation, focusing on a patient’s existing body chemistry and ability to manage an increased sodium load. Eligibility rules ensure that use aligns with the drug's properties as a systemic alkalinizer.

Contraindicated Populations (Must Not Use)

Use is absolutely prohibited for individuals with specific, high-risk conditions:

  • Metabolic Alkalosis: A pre-existing state of excessively high body pH.
  • Electrolyte Imbalances: Including low serum potassium (hypokalaemia) or high serum sodium (hypernatraemia).
  • Severe Sodium Sensitivity: Conditions that require strict sodium restriction, such as severe congestive heart failure (CHF) or eclampsia.
  • Known Hypersensitivity to the active substance, Sodium Bicarbonate.

Conditional Use and Restrictions

Official labels advise that use must be approached with caution for several patient groups due to the risk of fluid retention or electrolyte imbalance:

  • Organ Function Impairment: Patients with existing renal impairment (kidney problems) or hepatic impairment.
  • Cardiovascular Conditions: Individuals with hypertension (high blood pressure) or pre-existing oedema.
  • Dietary Restrictions: Patients who are following a strict low-sodium or salt-restricted diet.

Age and Life Stage Eligibility

Use is generally not established or not recommended in the pediatric population (children under 18 years of age) for systemic uses, and specific age restrictions apply for antacid use. During pregnancy and lactation, safety is officially not established; use is only permitted if advised by a healthcare professional.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nodosis (Sodium Bicarbonate) has documented interactions with numerous substances based on official regulatory information, primarily stemming from its ability to alter gastric and urinary pH.

One Formal Contraindication exists for co-administration with Eltrombopag. To avoid a significant reduction in the plasma exposure of Eltrombopag, the administrations must be separated by at least four hours.

Most interactions result in altered drug levels. Nodosis is documented to decrease the exposure of medications requiring an acidic environment for absorption, such as Ketoconazole and Atazanavir. Conversely, it may increase the plasma exposure of basic drugs like Quinidine and Amphetamines by reducing their renal clearance, which carries a risk of toxicity. Exposure is also reduced for drugs like Tetracycline antibiotics and Iron salts.

Regulatory documents establish mandatory Timing Separation Rules. Co-administration with most oral medicines requires separation by one to two hours. Specific classes like Tetracyclines and Fluoroquinolones require a separation of at least two hours.

A Pharmacodynamic interaction risk includes hypochloraemic alkalosis when used concurrently with potassium-depleting diuretics. Finally, the high sodium content requires consideration for patients with conditions like Heart Failure or Renal Insufficiency, and co-administration with large amounts of milk or milk products is restricted due to the documented risk of Milk-Alkali Syndrome.

Mechanism of Action

The mechanism of Nodosis is based on fundamental acid-base chemistry, operating solely by chemical buffering rather than interaction with classical receptors or enzymes. Its action is defined by the direct delivery of the bicarbonate ion ( HCO3^-), which functions as a proton acceptor against H^+ ions.

Local Chemical Neutralization in the Gastric Lumen

This immediate peripheral action occurs when the released HCO3^- directly neutralizes hydrogen ions ( H^+) in the stomach contents. This chemical reduction of acid concentration increases the local pH, commencing immediately upon the tablet's dissolution.

Systemic Buffering and pH Modulation

Upon absorption into the systemic circulation, HCO3^- augments the body’s endogenous bicarbonate buffer pool. This increases the overall buffering capacity of the blood toward excess circulating H^+ ions, resulting in an increase in the systemic pH.

Mechanistic Cascade and CO2 Elimination

The core buffering reaction produces carbonic acid ( H2 CO3), which rapidly dissociates into H2 O and gaseous carbon dioxide ( CO2). This mechanistic cascade requires CO2 expulsion, directly engaging the respiratory system as the clearance mechanism for the buffering byproduct.

Dosage and Administration Information

How to Use Nodosis

The usage of Nodosis (Oral Sodium Bicarbonate) is outlined to ensure appropriate administration, particularly concerning its use for systemic alkalinization and as an antacid. This section describes general principles for its administration, dosage, and frequency patterns.


Administration and Dosage Regimens

Nodosis is formulated for oral administration in tablet form. Dosing varies based on the intended purpose, following established ranges.

Feature Instruction Summary
Dosing Range Systemic Use: Typically 325 mg to 2000 mg per dose. Antacid Use: Single doses range from 650 mg to 2600 mg (1 to 4 tablets).
Frequency One to four times a day, or every four hours as needed for antacid use.
Maximum Dose Use for symptomatic relief should not exceed 2 weeks without professional supervision, adhering to specified maximum daily limits.

Administration Conditions and Populations

Certain preparation steps and age-specific limits are utilized for the correct use of the oral tablet. Administration is often advised to occur after meals or at bedtime when taken for its localized antacid effect.

  • Preparation: Depending on the tablet form, it may be required to be fully dissolved in a glass of water before ingestion, while non-effervescent tablets are typically swallowed whole with water.
  • Older Adults: Guidelines typically involve a lower maximum daily dose for adults aged 60 and over compared to younger adults, following a principle of conservative use in this population.

The administration method is oral, following a multiple-times-daily or as-needed schedule, with constraints defined by both dose limits and a time limit for acute usage.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Nodosis

The research evidence for Nodosis (Sodium Bicarbonate) is used in research to explore the correction of acid-base imbalances and provide insight into symptom changes related to stomach acid. The available studies help show what has been observed so far, according to major regulatory and scientific sources.


1. Evidence for Systemic Alkalinization in Chronic Kidney Disease

Research has explored the use of sodium bicarbonate in individuals with Chronic Kidney Disease (CKD) who also experience metabolic acidosis. These studies, primarily Randomized Controlled Trials (RCTs), consistently reported that the intervention was associated with an increase in serum bicarbonate, which reflects the correction of the measured acidosis. Studies monitored major outcomes, including the rate of kidney function decline ( eGFR) and hospitalization risk.

However, findings were mixed regarding the long-term outcomes related to kidney function decline. The evidence describing the long-term impact on eGFR and all-cause mortality is inconsistent across trials, and the follow-up durations were limited in some key studies, meaning long-term outcomes are not fully established.


2. Evidence for Quick Relief of Heartburn and Indigestion

For the second use, research has explored the role of Nodosis as an antacid to manage episodic or acute symptoms related to localized hyperacidity. Evidence is supported by regulatory recognition and pharmacokinetic studies, which focused on the compound's observable physiological response.

Research examined outcomes primarily by monitoring the change in gastric pH and the observed resolution of the associated symptoms of heartburn and indigestion. Findings related to this quick-acting symptom relief are considered well-established due to the straightforward neutralizing chemistry involved. However, comparative evidence is lacking against other classes of medication used for managing persistent symptoms.

Key Studies & References

  1. Sodium bicarbonate drug information

Frequently Asked Questions (FAQ)

Common questions about Nodosis (FAQ)


Q: What is the general difference between Nodosis and [Similar Drug Name]?

A: Nodosis (Sodium Bicarbonate) is classified by official sources as an antacid and a systemic alkalinizer. It works by direct chemical neutralization of acid in the body through chemical buffering. This mechanism differs from other acid-reducing medicines which may operate by blocking the receptors or pumps that produce acid in the stomach.


Q: How long does it typically take to see the effects of Nodosis?

A: For its intended use as an antacid for heartburn, the effect of Nodosis begins almost immediately upon dissolving in the stomach. For the systemic alkalinizing effect—which addresses the body’s overall acid-base balance—studies indicate that the peak increase in blood bicarbonate levels typically occurs between 60 and 90 minutes after oral ingestion.


Q: Is a headache a common side effect when starting Nodosis?

A: Headache is mentioned in the official product information as a side effect that may occur when taking this medicine. The core section on 'Possible side effects and safety information' lists the complete set of known adverse events described in official documents.


Q: Can Nodosis interact with common over-the-counter pain relievers?

A: Official drug labeling indicates that Nodosis may interact with certain over-the-counter pain relievers, particularly those in the Nonsteroidal Anti-inflammatory Drug (NSAID) class, such as aspirin. These interactions can affect how the body handles both medicines. Information regarding all prescription and non-prescription drugs, including pain relievers, is provided in the official drug label.


Q: Can Nodosis be crushed or split for easier swallowing?

A: Splitting or crushing a tablet is generally not advised unless the product label explicitly states that the tablet is scored for splitting, or unless the official prescribing information provides administration guidance to do so. Non-effervescent tablets are usually intended to be swallowed whole with water.


Q: Are the effects of Nodosis immediate, or do they build up over time?

A: The effects vary depending on the use: for quick heartburn relief, the effect is generally immediate. For uses targeting systemic acid-base balance, the action is more cumulative and blood levels are observed to increase over the first hour or two following a dose.


Q: Is Nodosis a type of antibiotic or an anti-inflammatory drug?

A: Nodosis (Sodium Bicarbonate) is not an antibiotic (which targets bacteria) or an anti-inflammatory drug. It is officially classified as a Systemic Alkalinizer and Antacid, a type of medicine that works to balance the body's acid levels through chemical means.


Q: How long does Nodosis stay in the system after the last dose?

A: The active ingredient, Sodium Bicarbonate, is eliminated by the body primarily through the kidneys and by the lungs as carbon dioxide. Official pharmacokinetic information does not define a specific half-life (the time it takes for half of the drug to be eliminated) for this compound.


Q: Does Nodosis cause weight gain or loss?

A: Official safety warnings note that Nodosis contains sodium and is associated with a risk of fluid retention or edema (swelling) in some individuals, particularly those with pre-existing conditions. Fluid retention may be observed as weight gain.


Q: Can Nodosis affect mood or energy levels?

A: Regulatory documents list 'mood or mental changes' and 'unusual tiredness or weakness' as possible adverse effects. These effects are described in official documents as potential adverse events.


Q: Is Nodosis associated with any risk of dependence?

A: Official product information, based on clinical experience and regulatory review, states that no habit-forming tendencies have been reported for this medicine.


Q: How do people report feeling when they first start taking Nodosis?

A: When starting this medicine, some people may experience common gastrointestinal effects. These are typically related to the chemical reaction in the stomach and can include belching, flatulence (gas), abdominal distention (bloating), or stomach cramps.


Q: Is there a generic version of Nodosis available?

A: The active ingredient in Nodosis is Sodium Bicarbonate, which is a common compound. This compound is widely available in generic, over-the-counter, and non-prescription forms.


Q: Do health professionals generally view Nodosis as a first-line treatment?

A: Nodosis (Sodium Bicarbonate) is officially indicated for the correction of metabolic acidosis and for use as an antacid. The standard use of any medicine is based on a professional's assessment of the patient's condition and specific guidelines.


Q: Is Nodosis known to cause skin reactions or rashes?

A: Severe allergic reactions are documented in the official safety information. These rare reactions may include symptoms like skin rash, itching, or swelling, and are noted as reactions that may be severe.


Q: What should be done if a dose of Nodosis is missed?

A: If a dose is missed, regulatory patient information advises taking it as soon as it is remembered. However, if the next scheduled dose is close (e.g., within two hours), the missed dose should be skipped and the normal schedule resumed. The information provided in patient labeling states that the missed dose should not be doubled.


Q: Can Nodosis be taken on an empty stomach?

A: Official guidance indicates that Nodosis can be taken with or without food. However, for its antacid use, administration is often advised to occur after meals or at bedtime.


Q: Are there different forms (tablet, capsule, liquid) of Nodosis available?

A: The active ingredient in Nodosis, Sodium Bicarbonate, is available in multiple forms for oral use as a generic compound. These forms include tablet, granule, and solution.


Q: Is Nodosis usually a short-term or a long-term treatment?

A: For its use as an antacid, this medicine is typically intended for short-term use and should not exceed two weeks without medical guidance. Official safety warnings generally caution against prolonged use due to the risk of developing systemic alkalosis.


Q: Are there warnings about mixing Nodosis with herbal supplements?

A: Official safety information includes a general statement that the use of other substances, including herbs and supplements, should be noted. This information is provided to help prevent potential interactions with the medicine.


Q: What should be avoided when taking Nodosis?

A: You should avoid co-administering this medicine with large amounts of milk or milk products due to the risk of a serious condition called Milk-Alkali Syndrome. Additionally, avoid or separate dosing from certain medications, including certain antibiotics, iron salts, and some pain relievers, as detailed in the 'Interactions' section.


Q: Why is Nodosis sometimes taken for conditions other than its primary use?

A: In addition to its primary uses for metabolic acidosis and general antacid relief, official documents list other therapeutic uses. These include promoting urinary alkalinization and managing certain drug toxicities by changing the body's pH balance.


Q: Is it acceptable to take Nodosis with milk or juice?

A: Official warnings strongly advise avoiding co-administration with large amounts of milk or milk products due to the risk of Milk-Alkali Syndrome. No specific warning against taking it with fruit juice is noted in the regulatory labeling.


Q: Are there any reported issues with liver function while taking Nodosis?

A: Official documents advise that the medicine should be used with caution in patients with pre-existing liver problems. Warnings regarding pre-existing liver conditions are included in the product's official safety information.


Q: Can Nodosis be used by children?

A: For systemic uses, use is generally not established for the pediatric population (children under 18 years of age). For its antacid use, specific dosing guidelines are provided for children aged 6 to 12 years in some forms, though official labeling may restrict use in children under 12.


Q: Does Nodosis have known interactions with blood pressure medication?

A: Because Nodosis has a high sodium content, warnings are in place for individuals with high blood pressure (hypertension) or those taking medications for heart conditions. This is because the sodium content may affect fluid and electrolyte balance in the body.

How should Nodosis be stored and disposed of?

Official Storage Requirements

Nodosis (Sodium Bicarbonate tablets) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). Temperature fluctuations outside of this range are permitted only between 15 C and 30 C (59 F and 86 F).

Protection from moisture is a critical requirement for stability. The official labeling mandates that the product be stored in a tight container, and the container must be kept tightly closed when not in use.

Handling and Disposal

For child safety, the product must be stored out of the sight and reach of children at all times. When disposing of unused or expired medicine, official guidance advises against flushing the tablets down a toilet or pouring them into a drain. Disposal should follow established local drug take-back or collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nodosis found in:

A-Z Index: